LB Pharmaceuticals Inc (LBRX) Stock Total Returns
Growth of $10,000 chart
2025-09-11 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$15,358
Total Return
53.58%
CAGR
107.29%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +8.47% |
| Median | +5.60% |
| Best | +46.20% |
| Worst | -10.91% |
| % of Windows Positive | 73.2% |
1-Year (252 Trading Days)
3-Year (756 Trading Days)
Risk Metrics
| Maximum Drawdown | -15.57% |
| Average Drawdown | -6.52% |
| Drawdown Duration | 20 Trading Days |
| Sortino Ratio | 2.35 |
| Calmar Ratio | 6.89 |
| CVaR (5%) | -7.26% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +19.36% (+86.19% ann.) | +$1936.21 | $0.00 | $0.00 | $0.00 |
| 2025 partial | +28.67% (+129.22% ann.) | +$2867.05 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 11, 2025 – April 14, 2026 | +53.58% | +107.29% | +$5358.38 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.